BRIDGEWATER, N.J., March 1,
2023 /PRNewswire/ -- Insmed Incorporated (Nasdaq:
INSM), a global biopharmaceutical company on a mission to transform
the lives of patients with serious and rare diseases, today
announced that management will present at the following investor
conferences:
- The Cowen 43rd Annual Healthcare Conference in
Boston on Wednesday, March 8, 2023, at 12:50 p.m. ET in a fireside chat
- The Barclays Global Healthcare Conference in Miami on Wednesday,
March 15, 2023, at 4:05 p.m.
ET in a fireside chat
Each fireside chat will be webcast live and can be accessed by
visiting the investor relations section of the Company's website
at www.insmed.com. Each webcast will be archived for a period
of 30 days following the conclusion of the live event.
About Insmed
Insmed Incorporated is a global biopharmaceutical company on a
mission to transform the lives of patients with serious and rare
diseases. Insmed's first commercial product is a first-in-disease
therapy approved in the United States, Europe,
and Japan to treat a chronic, debilitating lung disease.
The Company is also progressing a robust pipeline of
investigational therapies targeting areas of serious unmet need,
including neutrophil-mediated inflammatory diseases and rare
pulmonary disorders. Insmed is headquartered in Bridgewater,
New Jersey, with a footprint
across Europe and in Japan. For more information, visit
www.insmed.com.
Contact:
Investors:
Eleanor Barisser
Associate Director, Investor Relations
Insmed
(718) 594-5332
eleanor.barisser@insmed.com
Media:
Mandy Fahey
Executive Director, Corporate Communications
Insmed
(732) 718-3621
amanda.fahey@insmed.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/insmed-to-present-at-two-march-conferences-301757060.html
SOURCE Insmed Incorporated